Ventas, Inc.
VTRReal Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.
- Revenue
- +23.0%
- EPS
- −7.14%
- Free cash flow
- +20.5%
- Total debt
- −1.07%
Quarter to September 2026, against a year earlier
After hours trading: 86.55, down 0.02%, last trade 7:28pm Eastern.
Follow VTR
Alert me
Ventas, Inc. (VTR) Return on equity
Ventas, Inc.'s return on equity over the twelve months to Sep 30, 2026 was 1.85%, down 0.3 percentage points from fiscal 2025 (2.15%). Over the past ten years it has ranged from −0.45% (fiscal 2022) to 12.6% (fiscal 2017); the current reading is higher than 45% of that period. That is below the Reit Healthcare Facilities industry median of 4.65% and below the Real Estate sector median of 2.69%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 2.15% | 1.35 |
| FY2024 | 0.80% | 1.21 |
| FY2023 | −0.41% | 0.04 |
| FY2022 | −0.45% | (0.91) |
| FY2021 | 0.46% | (3.76) |
| FY2020 | 4.22% | 0.06 |
| FY2019 | 4.16% | 0.30 |
| FY2018 | 3.86% | (8.78) |
| FY2017 | 12.6% | 6.20 |
| FY2016 | 6.44% | 1.89 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| NHI National Health Investors, Inc. compare | 38.8% |
| OHI Omega Healthcare Investors, Inc. compare | 14.1% |
| CTRE CareTrust REIT, Inc. compare | 7.78% |
| DOC Healthpeak Properties, Inc. compare | 3.97% |
| WELL Welltower Inc. compare | 3.76% |
| SBRA Sabra Healthcare REIT, Inc. compare | 2.52% |
| AHR American Healthcare REIT, Inc. compare | 2.32% |
| VTR Ventas, Inc. | 1.85% |
| HR Healthcare Realty Trust Incorporated compare | −1.01% |
| Reit Healthcare Facilities industry median | 4.65% |
| Real Estate sector median | 2.69% |
| Market median | 1.97% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on VTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement